Archives

Perioperative Management of Warfarin Interruption

About this Course

UConn has developed web-based continuing pharmacy education activities to enhance the practice of pharmacists and assist pharmacists in making sound clinical decisions to affect the outcome of anticoagulation therapy for the patients they serve. There are a total of 12 hours of CPE credit available. Successful completion of these 12 hours (13 activities) or equivalent training will prepare the pharmacist for the Anticoagulation Traineeship, which described below in the Additional Information Box.

The activities below are available separately for $17/hr or as a bundle price of $140 for all 13 activities (12 hours). These are the pre-requisites for the anticoagulation traineeship. Any pharmacist who wishes to increase their knowledge of anticoagulation may take any of the programs below.

When you are ready to submit quiz answers, go to the Blue "Take Test/Evaluation" Button.

Target Audience

Pharmacists who are interested in making sound clinical decisions to affect the outcome of anticoagulation therapy for the patients they serve.

This activity is NOT accredited for technicians.

Pharmacist Learning Objectives

At the end of this application-based continuing education activity, the learner will be able to:

  1. Review recommendations for when to interrupt warfarin therapy.
  2. Review guidelines for determining thromboembolic risk.
  3. Review recommendations for bridging therapy implementation.
  4. Review cases for appropriate method to manage warfarin interruption based on risk stratification.
  5. Apply case-specific monitoring parameters for anticoagulation bridge therapy.

Release Date

Released:  06/01/2022
Expires:  05/31/2025

Course Fee

$17

ACPE UAN

ACPE #0009-0000-22-036-H01-P

Session Code

22AC36-MXT39

Accreditation Hours

1.0 hour of CE

Bundle Options

If desired, “bundle” pricing can be obtained by registering for the activities in groups. It consists of thirteen anticoagulation activities in our online selection.

You may register for individual topics at $17/CE Credit Hour, or for the Entire Anticoagulation Pre-requisite Series.

Pharmacist General Registration for 13 Anticoagulation Pre-requisite activities-(12 hours of CE)  $140.00

In order to attend the 2-day Anticoagulation Traineeship, you must complete all of the Pre-requisite Series or the equivalent.

Additional Information

Anticoagulation Traineeship at the University of Connecticut Health Center, Farmington, CT

The University of Connecticut School of Pharmacy and The UConn Health Center Outpatient Anticoagulation Clinic have developed 2-day practice-based ACPE certificate continuing education activity for registered pharmacists and nurses who are interested in the clinical management of patients on anticoagulant therapy and/or who are looking to expand their practice to involve patient management of outpatient anticoagulation therapy. This traineeship will provide you with both the clinical and administrative aspects of a pharmacist-managed outpatient anticoagulation clinic. The activity features ample time to individualize your learning experience. A “Certificate of Completion” will be awarded upon successful completion of the traineeship.

More Information About Traineeship

Accreditation Statement

ACPE logo

The University of Connecticut, School of Pharmacy, is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.  Statements of credit for the online activity ACPE #0009-0000-22-036-H01-P will be awarded when the post test and evaluation have been completed and passed with a 70% or better. Your CE credits will be uploaded to your CPE monitor profile within 2 weeks of completion of the program.

Grant Funding

There is no grant funding for this activity.

Requirements for Successful Completion

To receive CE Credit go to Blue Button labeled "take Test/Evaluation" at the top of the page.

Type in your NABP ID, DOB and the session code for the activity.  You were sent the session code in your confirmation email.

Faculty

Victoria Lambert, Pharm.D., CACP
Clinical Coordinator
William W. Backus Hospital
Norwich, CT

Janki S. Shah, PharmD, BCACP
William W. Backus Hospital,
Norwich, CT

Faculty Disclosure

In accordance with the Accreditation Council for Pharmacy Education (ACPE) Criteria for Quality and Interpretive Guidelines, The University of Connecticut School of Pharmacy requires that faculty disclose any relationship that the faculty may have with commercial entities whose products or services may be mentioned in the activity.

Drs. Lambert and Shah have no relationships with any ineligible companies and therefore have nothing to disclose.

Disclaimer

The material presented here does not necessarily reflect the views of The University of Connecticut School of Pharmacy or its co-sponsor affiliates. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.

Program Content

Program Handouts

Post Test Evaluation

View Questions for Perioperative Management of Warfarin Interruption

 1. A patient presents to your clinic and informs you that he is having a colonoscopy.  He wants to know what to do with his warfarin for the procedure and seeks out your advice.

  1. Tell the patient to contact his PCP
  2. Review the patients indication for warfarin therapy and provide appropriate recommendations to PCP
  3. Stop warfarin for 5 days and bridge with LMWH
  4. Continue warfarin

 

2. Which is the correct description of CHADS2 scoring?

  1. CHF, hypertension, age >65, DM, prior history of stroke
  2. Cardiomyopathy, hypertension, age >75, DM, prior history of stroke
  3. CHF, hypertension, age > 75, DM, prior history of stroke
  4. CHF, hyperlipidemia, age >75, DM, prior history of stroke

 

3. TL is a 75 year old male on warfarin indefinitely for atrial fibrillation.  His CHADS2 score is 5. TL is scheduled for a biopsy of his bladder. Per coordination with his cardiologist, LMWH bridging is ordered and implemented according to your clinic protocol.  Three days after the procedure, he continues to have hematuria and the urologist advises to hold warfarin but continue LMWH due to his high CHADS2 score.  The urologist seeks your advice on the appropriate dose of LMWH.

  1. Continue full treatment dose and order antiXa levels
  2. Reduce the dose of LMWH to a prophylactic regimen until hematuria resolves, then resume warfarin and continue LMWH bridging until INR is therapeutic
  3. Stop LMWH and continue warfarin as it will take several days for warfarins fullest effects
  4. Defer to cardiology

 

4. Warfarin therapy must be interrupted for the following:

  1. Mole excision
  2. Hip Replacement surgery
  3. Cortisone injection in the knee
  4. Epidural
  5. B and D

 

Case Studies in Drug Interactions with Anticoagulation Therapy

About this Course

UConn has developed web-based continuing pharmacy education activities to enhance the practice of pharmacists and assist pharmacists in making sound clinical decisions to affect the outcome of anticoagulation therapy for the patients they serve. There are a total of 12 hours of CPE credit available. Successful completion of these 12 hours (13 activities) or equivalent training will prepare the pharmacist for the Anticoagulation Traineeship, which described below in the Additional Information Box.

The activities below are available separately for $17/hr or as a bundle price of $140 for all 13 activities (12 hours). These are the pre-requisites for the anticoagulation traineeship. Any pharmacist who wishes to increase their knowledge of anticoagulation may take any of the programs below.

When you are ready to submit quiz answers, go to the Blue "Take Test/Evaluation" Button.

Target Audience

Pharmacists who are interested in making sound clinical decisions to affect the outcome of anticoagulation therapy for the patients they serve.

This activity is NOT accredited for technicians.

Pharmacist Learning Objectives

At the end of this application-based continuing education activity, the learner will be able to:

  1. Identify clinically significant drug interactions with anticoagulation therapy.
  2. Discuss drug interactions that patients may hear about, but are generally not clinically significant.
  3. Analyze cases to determine if a drug interaction is clinically significant.
  4. Formulate plans for the identified drug interactions in simulated cases.
  5. Formulate monitoring parameters for the identified drug interactions in the simulated cases.

Release Date

Released:  06/01/2022
Expires:  05/31/2025

Course Fee

$17

ACPE UAN

ACPE #0009-0000-22-037-H01-P

Session Code

22AC37-FWK49

Accreditation Hours

1.0 hour of CE

Bundle Options

If desired, “bundle” pricing can be obtained by registering for the activities in groups. It consists of thirteen anticoagulation activities in our online selection.

You may register for individual topics at $17/CE Credit Hour, or for the Entire Anticoagulation Pre-requisite Series.

Pharmacist General Registration for 13 Anticoagulation Pre-requisite activities-(12 hours of CE)  $140.00

In order to attend the 2-day Anticoagulation Traineeship, you must complete all of the Pre-requisite Series or the equivalent.

Additional Information

Anticoagulation Traineeship at the University of Connecticut Health Center, Farmington, CT

The University of Connecticut School of Pharmacy and The UConn Health Center Outpatient Anticoagulation Clinic have developed 2-day practice-based ACPE certificate continuing education activity for registered pharmacists and nurses who are interested in the clinical management of patients on anticoagulant therapy and/or who are looking to expand their practice to involve patient management of outpatient anticoagulation therapy. This traineeship will provide you with both the clinical and administrative aspects of a pharmacist-managed outpatient anticoagulation clinic. The activity features ample time to individualize your learning experience. A “Certificate of Completion” will be awarded upon successful completion of the traineeship.

More Information About Traineeship

Accreditation Statement

ACPE logo

The University of Connecticut, School of Pharmacy, is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.  Statements of credit for the online activity ACPE #0009-0000-22-037-H01-P will be awarded when the post test and evaluation have been completed and passed with a 70% or better. Your CE credits will be uploaded to your CPE monitor profile within 2 weeks of completion of the program.

Grant Funding

There is no grant funding for this activity.

Requirements for Successful Completion

To receive CE Credit go to Blue Button labeled "take Test/Evaluation" at the top of the page.

Type in your NABP ID, DOB and the session code for the activity.  You were sent the session code in your confirmation email.

Faculty

Philip M. Hritcko, Pharm.D., CACP
Dean, School of Pharmacy
UConn School of Pharmacy
Storrs, CT

Faculty Disclosure

In accordance with the Accreditation Council for Pharmacy Education (ACPE) Criteria for Quality and Interpretive Guidelines, The University of Connecticut School of Pharmacy requires that faculty disclose any relationship that the faculty may have with commercial entities whose products or services may be mentioned in the activity.

Dr. Hritcko has no relationship with an ineligible company and therefore has nothing to disclose.

Disclaimer

The material presented here does not necessarily reflect the views of The University of Connecticut School of Pharmacy or its co-sponsor affiliates. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.

Program Content

Program Handouts

Post Test Evaluation

View Questions for Case Studies in Drug Interactions with Anticoagulation Therapy

1. You are not familiar with drug X. How would you determine if a drug interaction is likely between drug X and warfarin?

  1. Check drug X prescribing information
  2. Evaluate metabolic characteristics of drug X
  3. Review case reports through Medline
  4. Request information from the manufacturers of warfarin
  5. All of the above

2.Warfarin is a racemic mixture of both R- and S- warfarin. What is the primary route of elimination for the S-warfarin version of this racemic mixture?

  1. Renal
  2. Hepatic CYP1A2, CYP3A4
  3. Hepatic CYP2C15
  4. Hepatic CYP2C9

3. Acute alcohol use “binge drinking” would have what effect on the INR of a patient who has been stable on warfarin anticoagulation therapy?

  1. INR value would go down
  2. INR value would remain the same
  3. INR value would go up
  4. None of the above

Patient Case:

JM is a 35 YO female with a history of DVT and is on chronic warfarin therapy with an INR goal of 2.0-3.0.  JM is not taking any other meds and has discontinued her birth control tablets several years earlier due to the association with her developing a DVT.  JM decides to self-treat what is believed to be a vaginal yeast infection with miconazole nitrate vaginal cream for 7 days.

4. Based upon the information provided in this patient case should you be concerned about JM self-treating her yeast infection?

  1. Yes
  2. No
  3. Undecided

5. Based upon the information provided in this case what would you expect to happen to JM’s INR level after 3-4 days of her using the miconazole nitrate vaginal cream?

  1. INR would go up
  2. INR would remain the same
  3. INR would go down
  4. None of the above

6. Based upon the information that you have on patient JM when should you schedule her next INR testing time?

  1. Recheck INR in 1 month
  2. Recheck INR in 2 weeks
  3. Recheck INR in 3-4 days
  4. Recheck INR in 90 days

7. Warfarin decreases the production of which of the following vitamin K dependent clotting factors?

  1. II
  2. VII
  3. IX
  4. X
  5. All of the above

8. Which of the following best describes examples of pharmacodynamic mechanisms for drug interactions?

  1. Protein binding
  2. Enzyme induction
  3. Synergism
  4. None of the above

9. Which of the following oral anticoagulant agents currently has an approved reversal agent to reverse their anticoagulant actions?

  1. Fondaparinux
  2. Rivaroxaban
  3. Warfarin
  4. Dabigatran
  5. Both c and d above

10. The best over-the-counter (OTC) self-treatment option for a patient with minor headaches, aches and pains who is also taking warfarin is acetaminophen (APAP). Why would you recommend APAP over aspirin or NSAIDs to a patient on warfarin?

  1. APAP does not inhibit platelet function
  2. APAP does not cause injury to the GI mucosa
  3. APAP is highly protein bound
  4. Both a and b above

Hypercoagulable States

About this Course

UConn has developed web-based continuing pharmacy education activities to enhance the practice of pharmacists and assist pharmacists in making sound clinical decisions to affect the outcome of anticoagulation therapy for the patients they serve. There are a total of 12 hours of CPE credit available. Successful completion of these 12 hours (13 activities) or equivalent training will prepare the pharmacist for the Anticoagulation Traineeship, which described below in the Additional Information Box.

The activities below are available separately for $17/hr or as a bundle price of $140 for all 13 activities (12 hours). These are the pre-requisites for the anticoagulation traineeship. Any pharmacist who wishes to increase their knowledge of anticoagulation may take any of the programs below.

When you are ready to submit quiz answers, go to the Blue "Take Test/Evaluation" Button.

Target Audience

Pharmacists who are interested in making sound clinical decisions to affect the outcome of anticoagulation therapy for the patients they serve.

This activity is NOT accredited for technicians.

Pharmacist Learning Objectives

At the end of this application-based continuing education activity, the learner will be able to:

  1. Describe inherited hypercoagulable states.
  2. Describe acquired hypercoagulable states.
  3. Apply management strategies for various hypercoagulable states including: Antithrombin III Deficiency, Protein C or S Deficiency, Factor V Leiden, Prothrombin gene mutation, Hyperhomocysteinemia and Antiphospholipid Antibody Syndrome.

Release Date

Released:  06/01/2022
Expires:  05/31/2025

Course Fee

$17

ACPE UAN

ACPE #0009-0000-22-034-H01-P

Session Code

22AC34-XYX89

 

Accreditation Hours

1.0 hour of CE

Bundle Options

If desired, “bundle” pricing can be obtained by registering for the activities in groups. It consists of thirteen anticoagulation activities in our online selection.

You may register for individual topics at $17/CE Credit Hour, or for the Entire Anticoagulation Pre-requisite Series.

Pharmacist General Registration for 13 Anticoagulation Pre-requisite activities-(12 hours of CE)  $140.00

In order to attend the 2-day Anticoagulation Traineeship, you must complete all of the Pre-requisite Series or the equivalent.

Additional Information

Anticoagulation Traineeship at the University of Connecticut Health Center, Farmington, CT

The University of Connecticut School of Pharmacy and The UConn Health Center Outpatient Anticoagulation Clinic have developed 2-day practice-based ACPE certificate continuing education activity for registered pharmacists and nurses who are interested in the clinical management of patients on anticoagulant therapy and/or who are looking to expand their practice to involve patient management of outpatient anticoagulation therapy. This traineeship will provide you with both the clinical and administrative aspects of a pharmacist-managed outpatient anticoagulation clinic. The activity features ample time to individualize your learning experience. A “Certificate of Completion” will be awarded upon successful completion of the traineeship.

More Information About Traineeship

Accreditation Statement

ACPE logo

The University of Connecticut, School of Pharmacy, is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.  Statements of credit for the online activity ACPE #0009-0000-19-026-H01-P will be awarded when the post test and evaluation have been completed and passed with a 70% or better. Your CE credits will be uploaded to your CPE monitor profile within 2 weeks of completion of the program.

Grant Funding

There is no grant funding for this activity.

Requirements for Successful Completion

To receive CE Credit go to Blue Button labeled "take Test/Evaluation" at the top of the page.

Type in your NABP ID, DOB and the session code for the activity.  You were sent the session code in your confirmation email.

Faculty

Anuja Rizal, Pharm.D., RPh, CACP
Anticoagulation Clinical Coordinator
University of Connecticut Health Center
Farmington, CT

Faculty Disclosure

In accordance with the Accreditation Council for Pharmacy Education (ACPE) Criteria for Quality and Interpretive Guidelines, The University of Connecticut School of Pharmacy requires that faculty disclose any relationship that the faculty may have with commercial entities whose products or services may be mentioned in the activity.

Dr. Rizal has no relationship with an ineligible company and therefore has nothing to disclose.

Disclaimer

The material presented here does not necessarily reflect the views of The University of Connecticut School of Pharmacy or its co-sponsor affiliates. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.

Program Content

Program Handouts

Post Test Evaluation

View Questions for Hypercoagulable States

1. Which of the following will not result in an acquired hypercoagulable state?

  1. Obesity
  2. Pregnancy
  3. Recent surgery
  4. Nephrotic syndrome
  5. None of the above

 

2. Which of the following has the most thrombogenic potential?

  1. Prothrombin gene mutation
  2. Factor V leiden
  3. Hyperhomocysteinemia
  4. Antithrombin III deficiency
  5. Protein C deficiency

 

3. Which of the following is the most commonly seen in Caucasians?

  1. Prothrombin gene mutation
  2. Factor V leiden
  3. Protein C deficiency
  4. Protein S deficiency
  5. Antithrombin III deficiency

 

4. Laboratory testing for which of the following is not affected by warfarin?

  1. Protein C deficiency
  2. Protein S deficiency
  3. Prothrombin gene mutation
  4. Antithrombin III deficiency
  5. All of the above

 

5. Management of patients with Protein C deficiency includes?

  1. Initiate pt’s presenting with VTE on heparin drip
  2. Ensure aPTT or factor Xa levels therapeutic before initiating warfarin
  3. Start low dose warfarin to avoid warfarin induced skin necrosis
  4. Lifelong anticoagulation following spontaneous thromboembolic event
  5. All of the above

 

6. Arterial thrombosis is reported but not typically associated with which of the following conditions?

  1. Protein C deficiency
  2. Factor V leiden
  3. Prothrombin gene mutation
  4. Antithrombin III deficiency
  5. All of the above

 

7. Factor V leiden causes

  1. Resistance of factor V to inactivation by activated protein C
  2. Guanine to adenine substitution at nucleotide 20210 of the prothrombin gene
  3. Unexplained recurrent late pregnancy loss
  4. A and C
  5. All of the above

 

8. Antiphospholipid antibody syndrome

  1. Can cause false elevation in INR
  2. Is difficult to diagnose because laboratory errors are very common
  3. Is associated with venous or arterial thromboembolism and pregnancy morbidity
  4. A and C
  5. All of the above

 

9. Hyperhomocysteinemia is noted in patients with deficiencies in

  1. Vitamin K
  2. Folic Acid
  3. Vitamin B6
  4. Vitamin B12
  5. B, C and D

 

10. Laboratory testing for hypercoagulable states should be?

  1. Performed on each patient that presents with VTE
  2. Reserved for patients presenting with suspected inherited thrombophilia based on family history or atypical presentation
  3. Performed on patient who presents with VTE after 8 hour plane ride
  4. Performed on patient who presents with VTE 1 week after surgery
  5. A & B

Anticoagulation Traineeship – Certificate Program

The University of Connecticut School of Pharmacy and The UConn Health Center Outpatient Anticoagulation Clinic have developed 2-day practice-based ACPE certificate continuing education activity for registered pharmacists and nurses who are interested in the clinical management of patients on anticoagulant therapy and/or who are looking to expand their practice to involve patient management of outpatient anticoagulation therapy. This traineeship will provide you with both the clinical and administrative aspects of a pharmacist-managed outpatient anticoagulation clinic. The activity features ample time to individualize your learning experience. A “Certificate of Completion” will be awarded upon successful completion of the traineeship.

I had a very successful and wonderful learning experience that I will treasure and WILL apply to my practice ASAP” – LKD

….this is a great program and I do not have enough good things to say about Dr. Durman and Dr. Bui.  They have amalgamated the art of customer service and patient care and have integrated my traineeship into their routine without any issues. ” – LP

“.….very comprehensive 2 days. I was able to see a lot!” – MS

Target Audience

This certificate program is for registered pharmacists and nurses who are interested in the clinical management of patients on anticoagulant therapy and/or who are looking to expand their practice to involve patient management of outpatient anticoagulation therapy.

Traineeship Learning Objectives

At the conclusion of the 2 day traineeship, pharmacists will be able to:

  1. Conduct patients interviews
  2. Evaluate current medications as it relates to anticoagulation therapy
  3. Describe the proper technique for obtaining point-of- care INR testing
  4. Adjust anticoagulant therapy for a patient based on desired outcome
  5. Prepare a patient-specific monitoring plan
  6. Formulate a note for the patient’s chart outlining your assessment and plan
  7. Describe how to bill for services

Pre-Requisites

  1. All participants must successfully complete the 12-hour online training at pharmacy.uconn.edu/academics/ce/anticoagulation or an equivalent training as approved by the Director of CE and the faculty of the traineeship.
  2. All participants must have a valid pharmacist, MD or nursing license
  3. All participants must provide documentation of current professional liability insurance
  4. All participants must complete the application (below)
  5. A telephone interview will be conducted prior to day 1 to discuss goals and expectations of the A copy of clinic’s policy and procedures will also be forwarded to the participant prior to the visit. Participants are expected to be familiar with the clinic’s policy and point-of-care testing manual.

Location

UConn Health Outpatient Services Anticoagulation Clinic
11 SOUTH ROAD
FARMINGTON, CT 06030
Suite 230 MC 6237

Email your completed application and proof of liability insurance to joanne.nault@uconn.edu. Once received, UConn will contact you with the date of attendance.

Spring 2025 dates!
Tuesday and Wednesday – March 25-26, 2025
Tuesday and Wednesday – April 15-16, 2025
Monday and Tuesday – April 28-29, 2025
Wednesday and Thursday – May 14-15, 2025
Tuesday and Wednesday – June 3-4

 

Agenda for Traineeship

Day 1
8:30-9:00 am Orientation to the clinic and staff, HR forms, review clinic workflow
9:00 am-12:30 pm Observation of patient interview process, point-of-care testing, dose decision making, and documentation procedures.
12:30 pm-1:00 pm Lunch
1:00 pm-3:00 pm Observed patient interviews and documentation
3:00 pm-3:30 pm Observed telephone patient interviews, and documentation
3:30 pm-4:30 pm Day 1 review and evaluation
Day2
8:30 am-9:00 am Q/A in preparation for day’s work
9:00 am-12:30 pm Solo telephone patient interviews, and documentation.
12:30 pm -1:00 pm Lunch
1:00 pm-1:30 pm Review of morning’s work
1:30 pm-2:30 pm Solo patient interviews, and documentation.
2:30 pm-4:30 pm Wrap up Q/A, address individual needs and final evaluation.

Activity Faculty

Anuja Rizal, RPh, PharmD, CACP, John Dempsey Hospital Anticoagulation Clinic Coordinator, Farmington, CT

Elizabeth Biron, PharmD, John Dempsey Hospital Anticoagulation Clinic Pharmacist, Farmington, CT

Damian Green, Pharmacy Technician, John Dempsey Hospital Anticoagulation Clinic, Farmington, CT

Faculty Disclosure

In accordance with the Accreditation Council for Pharmacy Education (ACPE) Criteria for Quality and Interpretive Guidelines, The University of Connecticut School of Pharmacy requires that faculty disclose any relationship that the faculty may have with commercial entities whose products or services may be mentioned in the activity.

Dr. Rizal does not have anything to disclose.

Dr. Biron does not have anything to disclose.

Activity Fees

Prerequisite Online content: can be found at www.pharmacy.uconn.edu/academics/ce/anticoagulation click on each of the listed activities to register.  If you register for the entire bundle, the pricing is discounted to $140 total rather than approximately $17/credit hour.

Live  content:  Please see above for available traineeship dates.  These dates are filled on a first come/first serve basis.

The Registration Fee of $500 includes all costs of the traineeship instruction and printed materials, but does not include the home study pre-requisites.

APPLICATION

Please call Joanne at 860-486-2084 with credit card information. Scan and email your completed application to the address below.

joanne.nault@uconn.edu

There is no reduced fee for UConn faculty, adjunct faculty,  preceptors or volunteers for this program

Refunds

The registration fee, less a $75 processing fee, is refundable for those that cancel their registration more than 14 days prior to your scheduled live program. After that time, no refund is available. Participant substitutions may be made at any time.

    Grant Funding

    There is no grant funding for this activity.

      ACPE logo

      The University of Connecticut, School of Pharmacy, is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Sixteen contact hours (1.6 CEU’s)  of practice-based certificate continuing education credit for pharmacists who participate in the traineeship and pass the competency evaluation with at least a “3” in all of the assessment categories. Credit will be automatically uploaded to the CPE Monitor system, and a certificate of completion will be mailed within 4 weeks of traineeship completion. UAN#0009-0000-23-003-L01-P

      Initial release date:  March 16, 2023
      Planned expiration date:  March 16, 2026

      Disclaimer:
      The material presented here does not necessarily reflect the views of The University of Connecticut School of Pharmacy or its co-sponsor affiliates. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.